Skip to main content
Equibles

STATE STREET CORP

Position in INMB — Inmune Bio, Inc.

CIK 93751 BOSTON, MA
Back to INMB Full portfolio

Position in INMB

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$152,181
-$176,512 QoQ
Shares Held
93,363
-67.9% QoQ
Ownership
0.336%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#14
of 83 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 76% Shared 0% None 24%

Common Shares in INMB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STATE STREET CORP holds $36,881,619,425 across 411 Biotechnology names. INMB ranks #353 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 11,871,459 $5,896,909,829
2 REGN
Regeneron Pharmaceuticals, Inc.
 4,834,688 $3,014,621,355
3 INCY
Incyte Corp
 9,722,336 $1,102,124,008
4 MRNA
Moderna, Inc.
 15,726,193 $1,101,305,295
5 ALNY
Alnylam Pharmaceuticals, Inc.
 3,555,689 $1,070,369,059
6 RVMD
Revolution Medicines, Inc.
 4,897,051 $917,119,711
7 RPRX
Royalty Pharma plc
 12,338,229 $691,804,500
8 INSM
INSMED Inc
 6,052,174 $645,282,791

All Filings in INMB

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $152,181 93,363
2026-03-31 $328,693 290,879
2025-12-31 $541,724 347,259
2025-09-30 $587,534 283,833
2025-06-30 $636,155 275,392
2025-03-31 $1,844,159 236,128
2024-12-31 $1,057,418 226,428
2024-09-30 $1,220,446 226,428
2024-06-30 $1,478,143 167,590
2024-03-31 $529,490 45,063
2023-12-31 $507,409 45,063
2023-09-30 $304,399 44,963
2023-06-30 $408,264 44,963
2023-03-31 $290,460 44,963
2022-12-31 $285,065 44,963
2022-09-30 $278,770 44,963
2022-06-30 $397,472 44,963
2022-03-31 $317,122 37,663
2021-12-31 $344,923 33,816
2021-09-30 $538,244 27,716
2021-06-30 $611,717 34,816